Reduced expression levels of let-7c in human breast cancer patients

Oncology Letters

Volumn 9, Issue 3, 2015, Pages 1207-1212

  Li, Xin Xin ^a   Gao, Shu Yan ^a   Wang, Ping Yu ^a   Zhou, Xue ^a   Li, You Jie ^a   Yu, Yuan ^a   Yan, Yun Fei ^a   Zhang, Han Han ^a   Lv, Chang Jun ^a   Zhou, Hui Hui ^b   Xie, Shu Yang ^a  

^a BINZHOU MEDICAL UNIVERSITY   (China)

^b QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

Breast cancer; Circulating miRNA; Let 7c; Predictive factor; Receiver operating characteristic analysis

Indexed keywords

ESTROGEN RECEPTOR; MICRORNA; MICRORNA LET 7C; PROGESTERONE RECEPTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST CANCER; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MENOPAUSE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

EID: 84921725148     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2015.2877     Document Type: Article

References (28)

1. Asaga S, Kuo C, Nguyen T, et al: Direct serum assay for microRNA-21 concentrations in early and advanced breast cancer. Clin Chem 57: 84-91, 2011.
2. Heneghan HM, Miller N, Lowery AJ, et al: MicroRNAs as novel biomarkers for breast cancer. J Oncol 2009: 950201, 2009.
3. Roth C, Rack B, Müller V, et al: Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer. Breast Cancer Res 12: R90, 2010.
4. Macfarlane LA and Murphy PR: MicroRNA: Biogenesis, function and role in cancer. Curr Genomics 11: 537-561, 2010.
5. Zhao B, Han H, Chen J, et al: MicroRNA let-7c inhibits migration and invasion of human non-small cell lung cancer by targeting ITGB3 and MAP4K3. Cancer Lett 342: 43-51, 2014.
6. Sempere LF, Freemantle S, Pitha-Rowe I, et al: Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biol 5: R13, 2004.
7. Pelosi A, Careccia S, Lulli V, et al: miRNA let-7c promotes granulocytic differentiation in acute myeloid leukemia. Oncogene 32: 3648-3654, 2013.
8. Qian B, Katsaros D, Lu L, et al: High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-beta1. Breast Cancer Res Treat 117: 131-140, 2009.
9. Wang PY, Sun YX, Zhang S, et al: Let-7c inhibits A549 cell proliferation through oncogenic TRIB2 related factors. FEBS Lett 587: 2675-2681, 2013.
10. Wu Q, Wang C, Lu Z, Guo L and Ge Q: Analysis of serum genome-wide microRNAs for breast cancer detection. Clin Chim Acta 413: 1058-1065, 2012.
11. Chen X, Ba Y, Ma L, et al: Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18: 997-1006, 2008.
12. Zhang HH, Pang M, Dong W, et al: miR-511 induces the apoptosis of radioresistant lung adenocarcinoma cells by triggering BAX. Oncol Rep 31: 1473-1479, 2014.
13. Wang PY, Sun YX, Zhang S, et al: Let-7c inhibits A549 cell proliferation through oncogenic TRIB2 related factors. FEBS Lett 587: 2675-2681, 2013.
14. Hu X, Guo J, Zheng L, et al: The heterochronic microRNA let-7 inhibits cell motility by regulating the genes in the actin cytoskeleton pathway in breast cancer. Mol Cancer Res 11: 240-250, 2013.
15. Piskounova E, Polytarchou C, Thornton JE, et al: Lin28A and Lin28B inhibit let-7 microRNA biogenesis by distinct mechanisms. Cell 147: 1066-1079, 2011.
16. Cui X, Schiff R, Arpino G, Osborne CK and Lee AV: Biology of progesterone receptor loss in breast cancer and its implications for endocrine therapy. J Clin Oncol 23: 7721-7735, 2005.
17. Diaz NM: Laboratory testing for HER2/neu in breast carcinoma: an evolving strategy to predict response to targeted therapy. Cancer Control 8: 415-418, 2001.
18. Kerlikowske K, Cook AJ, Buist DS, et al: Breast cancer risk by breast density, menopause and postmenopausal hormone therapy use. J Clin Oncol 28: 3830-3837, 2010.
19. Qin B, Xiao B, Liang D, et al: MicroRNA let-7c inhibits Bcl-xl expression and regulates ox-LDL-induced endothelial apoptosis. BMB Rep 45: 464-469, 2012.
20. Johnson SM, Grosshans H, Shingara J, et al: RAS is regulated by the let-7 microRNA family. Cell 120: 635-647, 2005.
21. Jones CI, Zabolotskaya MV, King AJ, et al: Identification of circulating microRNAs as diagnostic biomarkers for use in multiple myeloma. Br J Cancer 107: 1987-1996, 2012.
22. Sakurai M, Miki Y, Masuda M, et al: LIN28: a regulator of tumor-suppressing activity of let-7 microRNA in human breast cancer. J Steroid Biochem Mol Biol 131: 101-106, 2012.
23. Zhu XM, Wu LJ, Xu J, Yang R and Wu FS: Let-7c microRNA expression and clinical significance in hepatocellular carcinoma. J Int Med Res 39: 2323-2329, 2011.
24. Shimizu S, Takehara T, Hikita H, et al: The let-7 family of microRNAs inhibits Bcl-xL expression and potentiates sorafenib-induced apoptosis in human hepatocellular carcinoma. J Hepatol 52: 698-704, 2010.
25. Björner S, Fitzpatrick PA, Li Y, et al: Epithelial and stromal microRNA signatures of columnar cell hyperplasia linking Let-7c to precancerous and cancerous breast cancer cell proliferation. PLoS One 9: e105099, 2014.
26. Barnes DM and Hanby AM: Oestrogen and progesterone receptors in breast cancer: past, present and future. Histopathology 38: 271-274, 2001.
27. Sofi GN, Sofi JN, Nadeem R, et al: Estrogen receptor and progesterone receptor status in breast cancer in relation to age, histological grade, size of lesion and lymph node involvement. Asian Pac J Cancer Prev 13: 5047-5052, 2012.
28. Faheem M, Mahmood H, Khurram M, Qasim U and Irfan J: Estrogen receptor, progesterone receptor and Her 2 Neu positivity and its association with tumour characteristics and menopausal status in a breast cancer cohort from northern Pakistan. Ecancermedicalscience 6: 283, 2012.